Key facts
- This page summarizes Rajkumar Patil V's Form 4 filing for OKYO Pharma Ltd (OKYO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 29 Jul 2026, 16:45.
Rajkumar Patil V - 27 Jul 2026 Form 4 Insider Report for OKYO Pharma Ltd (OKYO)
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- OKYO
- Reported as of
- 27 Jul 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 29 Jul 2026, 16:45:21 UTC
- Prior SEC filing
- 29 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Raj Patil
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Rajkumar Patil V filed Form 4 for OKYO Pharma Ltd (OKYO) on 29 Jul 2026.
Change
- Previous filing in this sequence was filed on 29 Jul 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002124067
Primary reporting owner
Patil Rajkumar V.
- Relationship
- Chief Scientific Officer
- Address
- 14-15 CONDUIT ST, LONDON, UNITED KINGDOM
- Signature
- /s/ Raj Patil
- Signature date
- 29 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OKYO
transaction
COMMON STOCK
Award
- Transaction value
- Shares
- +3,363
- Change %
- +20%
- Price
- $1.49*
- Shares after
- 20,030
- Date
- 27 Jul 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.